Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MetaVia Inc. Director's Dealing 2020

Jan 9, 2020

34919_dirs_2020-01-09_7e63d783-e9c2-4fb9-a6c6-e677bf6b2bad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2019-12-30

Reporting Person: DONG-A ST CO., LTD (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2880612 Direct